Australia’s Biggest Stock at Risk From Sanofi, Roche Challenge
- CSL is the only health care stock among Australia’s 15 largest
- Sanofi, Takeda, Roche offer new drugs to increase competition
Photographer: Carla Gottgens/Bloomberg
This article is for subscribers only.
For a fresh perspective on the stories that matter for Australian business and politics, sign up for our new weekly newsletter.
The largest stock on Australia’s benchmark index is facing increased price pressure as it deals with rising competition in the global health care sector.